Abstract Number: 1512 • 2016 ACR/ARHP Annual Meeting
Bone Structural Deficits in Rheumatoid Arthritis: Impact of Muscle Mass and Density
Background/Purpose: Rheumatoid arthritis (RA) is associated with muscle loss, obesity, and osteoporotic fractures. Body composition and muscle quality are important regulators of bone strength among…Abstract Number: 1513 • 2016 ACR/ARHP Annual Meeting
FRAX Fracture Risk in Rheumatoid Arthritis – Assessments with and without Bone Mineral Density May Lead to Very Different Results in Individual Patients
Background/Purpose: Osteoporosis is a well-known complication in patients with rheumatoid arthritis (RA). The FRAX tool is an online computer-based algorithm developed by WHO to evaluate…Abstract Number: 1514 • 2016 ACR/ARHP Annual Meeting
Symptoms of Depression and Anxiety Predict Worse Disease Activity and Functional Disability in a Cohort of Established Rheumatoid Arthritis Patients
Background/Purpose: Depression and anxiety disorders are common in RA patients, with the most recent prevalence estimates indicating that 16.8% of RA patients have a diagnosis…Abstract Number: 1515 • 2016 ACR/ARHP Annual Meeting
Could Increase Levels of Dickkopf-1 Protein be Considered As a Potential Biomarker for Bone Resorption in Joint and Periodontal Disease in Patients with Early Rheumatoid Arthritis?
Background/Purpose: Periodontitis and rheumatoid arthritis (RA) are chronic destructive inflammatory diseases with significant worldwide prevalence. They are characterized by inflammatory lesions adjacent to bone destruction…Abstract Number: 1516 • 2016 ACR/ARHP Annual Meeting
Evidence of Labial Salivary Gland Epithelial Cell Activation from Patients with Rheumatoid Arthritis and Sicca Symptomatology
Background/Purpose: In primary Sjögren’s syndrome (pSS), labial minor salivary gland epithelial cells (LMSGEC) inappropriately express various molecules, including B7, HLA-DR, ICAM, as assessed previously by…Abstract Number: 1517 • 2016 ACR/ARHP Annual Meeting
Does Inflammatory Arthritis Really Improve during Pregnancy? a Systematic Review and Meta-Analysis
Background/Purpose: Disease activity is considered to improve in approximately 75% of patients with rheumatoid arthritis (RA) during pregnancy. This figure, however, is derived from…Abstract Number: 1518 • 2016 ACR/ARHP Annual Meeting
Immunoglobulin Binding Protein (BiP), an Antigen for CCP Sero-Positive Rheumatoid Arthritis Patients, Can Result in a False Positive Quantiferon-Gold Tuberculosis Test
Background/Purpose: Citrullinated BiP is a newly described target for cyclic citrullinated peptide(CCP). BiP in both serum and synovial fluid is over-expressed in RA patients and…Abstract Number: 1519 • 2016 ACR/ARHP Annual Meeting
How Much, and When, Does Autoimmune Thyroid Disease Increase the Risk of RA, and Does RA-Onset Impact the Risk of Autoimmune Thyroid Disease?
Background/Purpose: Autoimmune thyroid disease (AITD) is one of the most common autoimmune diseases, and occurs more often than expected in patients with Rheumatoid Arthritis (RA).…Abstract Number: 1520 • 2016 ACR/ARHP Annual Meeting
RA Flare after Total Hip and Total Knee Arthroplasty: Preliminary Outcomes at 1 Year
Background/Purpose: Post-op flares are frequent for RA patients after total hip (THA) and total knee arthroplasty (TKA), when medications are discontinued to mitigate infection…Abstract Number: 1521 • 2016 ACR/ARHP Annual Meeting
Disease Characteristics and Change of Arthritis Activity According to Treatment in Hepatitis B Surface Antigen Positive Rheumatoid Arthritis Patients
Background/Purpose: Rheumatoid arthritis (RA) treatment may differ according to hepatitis B state and consequently bring about different outcome of arthritis. Only a small number of…Abstract Number: 1522 • 2016 ACR/ARHP Annual Meeting
Disease Burden in Rheumatoid Arthritis (RA) Patients Who Have Secondary Osteoarthritis (OA) Is Lower Than in OA but Higher Than in RA with No Secondary OA
Background/Purpose: Recent data indicate that the disease burden experienced by patients with osteoarthritis (OA) is similar to or greater than in rheumatoid arthritis (RA) (EULAR…Abstract Number: 1523 • 2016 ACR/ARHP Annual Meeting
The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR
Background/Purpose: The disease activity score (DAS) is a method used to monitor disease activity in Rheumatoid Arthritis (RA). Diseases that cause chronic pain or mood…Abstract Number: 1524 • 2016 ACR/ARHP Annual Meeting
Suppletion Therapy May be Warranted in RA Patients with Co-Existent Subclinical Hypothyroidism
Background/Purpose: Autoimmune thyroid disease often coexists with RA and has been associated with an elevated cardiovascular (CV) risk, especially in hypothyroid patients. However, the existing…Abstract Number: 1525 • 2016 ACR/ARHP Annual Meeting
Pain, Physical Function, and Worry (But Not Depression and Poor Sleep) Lead to Greater Fatigue in RA
Background/Purpose: Some view fatigue as resulting from disease activity, while others see it as a natural consequence of the pain, disability, and the emotional burden…Abstract Number: 1526 • 2016 ACR/ARHP Annual Meeting
Serum y-Neuropeptide Levels and Its Relationship with Body Fat Mass and Clinical Characteristics in Rheumatoid Arthritis
Background/Purpose: Overweight and obesity are comorbidities that may increase the risk of cardiovascular disease in rheumatoid arthritis. Increase in in body fat is observed in…
ACR Meeting Abstracts